Report Type: Therapy Reports
Report Category: Blood Diseases
Report Subcategory: Febrile Neutropenia
Price: 2999.00
Date: December 2021

Febrile Neutropenia: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Febrile Neutropenia 
Febrile Neutropenia is a blood condition in which the individual contains fever symptoms along with the reduced number of neutrophils which are helpful in fighting against the infection.

Top 10 Companies:
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Pfizer Inc
Novartis AG
Merck & Co Inc
Bristol-Myers Squibb Co
Amgen Inc
Gilead Sciences Inc
Sumitomo Chemical Co Ltd
Teva Pharmaceutical Industries Ltd